Navigating Experience and Possibilities with Subcutaneous Infliximab as a Biobetter in IBD (Celltrion Healthcare)
Anthony Buisson 1
Axel Dignass 2
Edoardo Vincenzo Savarino 3
1 CHU Estaing Clermont-Ferrand
2 Agaplesion Markus Hospital, Goethe University
3 University of Padua, Division of Gastroenterology
Conference
UEG Week 2022
Publisher
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]